Findings in Fabry Disease Reported from Charles University and General University Hospital Prague (Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, ...)

Press/Media: Research

PeriodNov 8 2023

Media coverage

1

Media coverage

  • TitleFindings in Fabry Disease Reported from Charles University and General University Hospital Prague (Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, ...)
    Media name/outletClinical Trials Daily
    Country/TerritoryUnited States
    Date11/8/23
    PersonsMichael L. West